ExozymesEXOZ
13F holders, Q4 2025 (December 31)7holders +1
1new positions
0sold out
$10.90avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding Exozymes Inc. (EXOZ) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Vanguard Group Inc. ($344K), Geode Capital Management, LLC ($257K) and BlackRock, Inc. ($68K).
- Company
- Exozymes Inc.
- CUSIP
- 461874109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $22 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 7,302 shares bought and 4,624 shares sold, net +2,678 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Vanguard Group Inc. | 0.00% | Add +21.3% | 31,516 | $344K |
| Geode Capital Management, LLC | 0.00% | Add +2.2% | 23,562 | $257K |
| BlackRock, Inc. | 0.00% | Add +25.4% | 6,251 | $68K |
| Morgan Stanley | 0.00% | No change | 1,250 | $14K |
| Bank of America Corp. | 0.00% | Reduce -26.1% | 17 | $185 |
| UBS Group AG | 0.00% | Reduce -99.9% | 3 | $33 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2 | $22 |
"% of holder's portfolio" is EXOZ's weight in each manager's 13F, not the share of Exozymes Inc. the manager owns.